An Introduction to Risk Evaluation & Mitigation Strategies (REMS) 2019

An Introduction to Risk Evaluation & Mitigation Strategies (REMS) 2019 is a conference dedicated to the FDA thinking of which products qualify for a Risk Evaluation and Mitigation Strategies (REMS).

An Introduction to Risk Evaluation & Mitigation Strategies (REMS) 2019 covers topics such as:

• What products qualify for REMS?
• The background to REMS
• Discuss their introduction, maintenance and reporting assessments
• Understand the different categories of REMS
• Contrast the approach between the US and FDA for a RMP or REMS programme

An Introduction to Risk Evaluation & Mitigation Strategies (REMS) 2019 brings together:

• QA
• Pharmacovigilance personnel working in safety review and risk assessments
• EU QP PVs
• Clinical personnel